P2 ‐099: A tale of two provinces: Comparison of the successes and challenges of structured, stepwise development in two Canadian provincial research and evaluation imbedded HCV elimination strategies
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 157-158, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐097: Hepatitis C direct‐acting antiviral treatment failures: clinical characteristics and resistance testing from a real‐world setting
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 73-74, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐061: Validation of a low cost, point of care screening device for HCV antibody detection in low resource peri‐urban settings of Karachi, Pakistan
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 137-138, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐152: Barriers and facilitators to hepatitis B immunization among sex workers: implications for integrated HIV, STI, and viral hepatitis services
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 182-183, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

LBO ‐06: Retreatment with Sofosbuvir/Velpatasvir/Voxilaprevir for 12 weeks is safe and effective for patients who have previously received Sofosbuvir/Velpatasvir or Sofosbuvir/Velpatasvir/Voxilaprevir
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 193-193, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐047: Natural history of 647 cases of acute hepatitis B in a reference viral hepatitis clinic: 20 years of follow‐up
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 49-49, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐033: Histologic predictors of liver‐related outcomes and mortality in patients with chronic hepatitis B and non‐alcoholic fatty liver disease
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 21-22, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐106: Gilead sciences’ support of global efforts toward elimination of hepatitis C virus
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 161-161, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐002: Characterization of the HEV‐specific CD8 +  T‐cell response in acute and chronic Hepatitis E virus infection
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 113-114, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐095: Virological responses & liver functions in patients with HCV related cirrhosis after treatment with directly acting antivirals (DAAs), a real life experience from a tertiary care center in India
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 72-73, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P2 ‐161: Hepatitis B infection in Argentina five years after implementation of universal vaccination
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 186-186, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

LBP ‐006: Sofosbuvir‐ Daclatasvir: Effectiveness among cirrhotic and non‐cirrhotic genotype 1 to 4 HCV patients, in real world settings
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 197-197, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐134: Contribution of hepatitis D virus infection to risk of cirrhosis and hepatocellular carcinoma in the Gambia
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 94-95, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

P1 ‐056: Altered HBV‐specific CD4+ T‐cell Responses in HBV/HIV‐1 Co‐ versus HBV Mono‐infected Patients
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 52-53, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research

O ‐039: Extension of hepatitis C screening, diagnosis and treatment into the community: a low cost, point of care, test and treat model for Pakistan
Journal of Viral Hepatitis,Volume 25, Issue S2, Page 25-25, June 2018. (Source: Journal of Viral Hepatitis)
Source: Journal of Viral Hepatitis - June 13, 2018 Category: Infectious Diseases Source Type: research